GlycoMimetics, Inc. News Headlines

Get GLYC Alerts
*Delayed - data as of Apr. 17, 2014 11:17 ET 
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    GLYC Real Time
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
Basic Chart Interactive Chart
Company Headlines Press Releases Market Stream
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Filtered By
Ordered By

How GlycoMimetics (GLYC) Stock Stands Out in a Strong Industry - Tale of the Tape
4/11/2014 8:39:01 AM -

GlycoMimetics: A Promising Sickle Cell Disease Play
4/10/2014 9:39:00 AM - Seeking Alpha

Should GlycoMimetics (GLYC) Be On Your Radar Now? - Tale of the Tape
4/10/2014 8:48:01 AM -

GlycoMimetics Posts Loss
3/31/2014 12:26:00 PM - RTT News

GlycoMimetics To Present At Barclays Global Conference ; Webcast At 9:30 AM ET
3/13/2014 8:30:00 AM - RTT News

Biotechs Dominate IPO Calendar, But Most Post Negative Returns
2/6/2014 11:45:00 AM - Seeking Alpha

Biotechs dominate IPO calendar, but most post negative returns
2/6/2014 9:57:52 AM - Renaissance Capital

U.S. IPO Recap: 20 Companies File Or Set Terms For IPOs
1/14/2014 7:31:00 AM - Seeking Alpha

4 U.S. IPOs Planned For The Week Of Jan. 13
1/14/2014 7:03:00 AM - Seeking Alpha

US IPO Recap: Twenty companies file or set terms for IPOs
1/13/2014 9:26:01 AM - Renaissance Capital

4 US IPOs planned for the week of Jan 13
1/13/2014 8:00:03 AM - Renaissance Capital

GlycoMimetics prices upsized IPO at $8 per share
1/10/2014 8:46:55 AM - Renaissance Capital

GlycoMimetics drops IPO price to $8 and increases shares offered
1/7/2014 9:13:02 AM - Renaissance Capital

Orphan disease biotech GlycoMimetics revives IPO filing, removes original terms
12/20/2013 8:54:07 AM - Renaissance Capital

GlycoMimetics postpones $60 million IPO
11/8/2013 8:12:03 AM - Renaissance Capital

15 U.S. IPOs Planned For The Week Of Nov. 4
11/5/2013 7:57:00 AM - Seeking Alpha

Orphan disease biotech GlycoMimetics sets terms for $60 million IPO
10/28/2013 8:12:38 AM - Renaissance Capital